KR20200008127A - Process for preparing substituted phenylacetic acid derivative - Google Patents

Process for preparing substituted phenylacetic acid derivative Download PDF

Info

Publication number
KR20200008127A
KR20200008127A KR1020197035381A KR20197035381A KR20200008127A KR 20200008127 A KR20200008127 A KR 20200008127A KR 1020197035381 A KR1020197035381 A KR 1020197035381A KR 20197035381 A KR20197035381 A KR 20197035381A KR 20200008127 A KR20200008127 A KR 20200008127A
Authority
KR
South Korea
Prior art keywords
compound
formula
reaction
integer
alkyl group
Prior art date
Application number
KR1020197035381A
Other languages
Korean (ko)
Inventor
자오보 가오
휘 젠
셍민 리우
지에핑 리
창파 왕
준쳉 젱
비바오 구오
리앙 송
아킹 리우
카이 후
이장 메이
Original Assignee
제지앙 지우조우 파마슈티칼 컴퍼니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제지앙 지우조우 파마슈티칼 컴퍼니 리미티드 filed Critical 제지앙 지우조우 파마슈티칼 컴퍼니 리미티드
Publication of KR20200008127A publication Critical patent/KR20200008127A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/02Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of compounds containing imino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/20Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups being part of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/86Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/14Preparation of carboxylic acid esters from carboxylic acid halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/313Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/317Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/44Adipic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Abstract

본 발명은 약물의 합성 분야에 속하며, 치환된 페닐아세트산 유도체의 제조방법에 관한 것으로, 상세하게는 2-(4-((2-옥소시클로펜틸)메틸)페닐) 프로판산의 제조방법에 관한 것이다. 본 발명은 프리델-크래프츠 반응(Friedel-Crafts reaction), 교환 고리화 및 결합 반응과, 환원 반응을 포함한다. 이 제조방법은 종래 기술에 교시되었거나 그로부터 영감을 받지 않았다. 이 제조방법은 상업적인 규모의 생산에 적합하다. 동시에 본 발명은 록소프로펜 나트륨의 산업적인 생산을 위한 또 다른 기술적 방법을 제공한다.The present invention belongs to the field of synthesis of drugs, and relates to a method for preparing substituted phenylacetic acid derivatives, and more particularly, to a method for preparing 2- (4-((2-oxocyclopentyl) methyl) phenyl) propanoic acid. . The present invention includes Friedel-Crafts reaction, exchange cyclization and binding reaction, and reduction reaction. This method of manufacture has not been taught or inspired by the prior art. This manufacturing method is suitable for commercial scale production. At the same time the present invention provides another technical method for the industrial production of roxofene sodium.

Description

치환된 페닐아세트산 유도체의 제조방법Process for preparing substituted phenylacetic acid derivative

본 출원은 2017년 6월 13일에 중국 특허청에 제출한 출원 번호 201710438332.1, 및 “치환된 페닐아세트산 유도체의 제조방법”이란 명칭의 중국 특허 출원의 우선권을 주장한다. 이 특허의 내용은 모두 참조로서 본 출원에 인용된다.This application claims the priority of application No. 201710438332.1, filed with the Chinese Patent Office on June 13, 2017, and a Chinese patent application entitled “Method for preparing substituted phenylacetic acid derivatives”. The contents of this patent are all incorporated herein by reference.

본 발명은 약물의 합성 분야에 속하며, 치환된 페닐아세트산 유도체의 제조방법에 관한 것으로, 상세하게는 2-(4-((2-옥소시클로펜틸)메틸)페닐) 프로판산의 제조방법에 관한 것이다.The present invention belongs to the field of synthesis of drugs, and relates to a method for preparing substituted phenylacetic acid derivatives, and more particularly, to a method for preparing 2- (4-((2-oxocyclopentyl) methyl) phenyl) propanoic acid. .

치환된 페닐아세트산 유도체는 US 4161538등의 미국 특허에 개시되어 있으며, 구조식은 다음과 같다:Substituted phenylacetic acid derivatives are disclosed in US patents, such as US Pat. No. 4,161,538, wherein the formula is:

Figure pct00001
.
Figure pct00001
.

특허 US 4161538에서, 상기 유도체는 항염증제, 진통제 및 해열제 활성에 매우 우수한 효과를 갖는 것도 보고되어 있다.In patent US 4161538 it is also reported that the derivative has a very good effect on the activity of anti-inflammatory, analgesic and antipyretic agents.

상기 구조식에서 A가 산소이면, n의 값은 1이고, R1은 메틸이다. 이는 록소프로펜의 매우 대표적인 치환된 페닐아세트산 유도체이며, 구체적인 구조식은 다음과 같다:If A is oxygen in the above formula, the value of n is 1 and R 1 is methyl. This is a very representative substituted phenylacetic acid derivative of roxofene, with the specific structural formula:

Figure pct00002
.
Figure pct00002
.

록소프로펜은 비스테로이드성의 항염증제용 프로피온산 유도체의 약물이다. 또한, 이들 프로피온산 유도체는 이부프로펜 및 나프록센도 포함한다. 록소프로펜은 브라질, 멕시코 및 일본에서 나트륨 염의 형태로 산쿄(Sankyo)사가 판매하고 있다. 일본, 아르헨티나 및 인도에서 록소프로펜 나트륨의 상표명은 Loxonin, Oxeno 및 Loxomac이다. 록소프로펜 나트륨은 이들 국가에서 경구 투여용으로 사용되며, 주사 투여 형태는 2006년 1월에 일본에서 판매가 승인되었다.Roxopropene is a drug of propionic acid derivatives for nonsteroidal anti-inflammatory drugs. These propionic acid derivatives also include ibuprofen and naproxen. Roxopropene is sold by Sankyo in the form of sodium salts in Brazil, Mexico and Japan. In Japan, Argentina and India, the trade names for roxofene sodium are Loxonin, Oxeno and Loxomac. Roxopropene sodium is used for oral administration in these countries, and the injection dosage form was approved for sale in Japan in January 2006.

특허 US 4161538에는 다음에 나타낸 옥소프로펜의 합성 경로를 개시하며, 여기서, n의 값이 1이고, R1은 메틸이다.Patent US 4161538 discloses the synthetic route of oxopropene shown below, wherein the value of n is 1 and R 1 is methyl.

Figure pct00003
.
Figure pct00003
.

중국 학술지 메디시널 케미스트리(medicinal chemistry) 20 (1), 25-28, 2010에서는, 4-메틸아세토페논을 출발 물질로서 사용하여 수소화붕소 나트륨에 의한 환원을 통해 화합물 I을 제공하였다. 화합물 I은 정제 없이 직접 염소화chhlorinated)하여 화합물 II를 얻는다. 화합물 II는 상 전이 촉매의 존재하에 염소화하여 화합물 III을 제공한다. 다음에, 화합물 III은 알칼리 가열 조건하에 가수분해 및 산성화하여 화합물 IV를 얻는다. 화합물 IV는 개시제로서 과산화 벤조일로 브롬화하여 화합물 V를 얻는다. 화합물 V는 메탄올로 에스테르화하여 화합물 VI을 얻은 다음, 알칼리성 조건하에 2-에톡시카보닐 시클로펜타논과 축합시켜 화합물 VII을 얻는다. 다음에, 화합물 VII은 48%의 HBr 및 아세트산 계에서 가열하면서 가수분해 및 탈카복실화하여 록소프로펜 나트륨을 얻는다. 합성 경로는 다음에 나타낸 바와 같다.In Chinese journal Medical chemistry 20 (1), 25-28, 2010, Compound I was provided via reduction with sodium borohydride using 4-methylacetophenone as starting material. Compound I is directly chlorinated without purification to give Compound II. Compound II is chlorinated in the presence of a phase transfer catalyst to provide compound III. Compound III is then hydrolyzed and acidified under alkaline heating conditions to yield Compound IV. Compound IV is brominated with benzoyl peroxide as initiator to give compound V. Compound V is esterified with methanol to give compound VI, followed by condensation with 2-ethoxycarbonyl cyclopentanone under alkaline conditions to give compound VII. Compound VII is then hydrolyzed and decarboxylated with heating in 48% HBr and acetic acid system to give roxofene sodium. The synthetic route is as shown below.

Figure pct00004
Figure pct00004

록소프로펜 나트륨의 양호한 의학적 전망이 있으나, 상기 경로는 산업적인 생산을 위해서 적합하지 않으므로, 산업적으로 합성할 수 있는 신규한 록소프로펜 경로를 개발할 필요가 있다.While there is a good medical prospect of roxofene sodium, the route is not suitable for industrial production, and there is a need to develop novel roxofene penetrate pathways that can be synthesized industrially.

본 발명은 치환된 페닐아세트산 유도체 또는 약학적으로 허용되는 그의 비독성 염 형태를 제조하기 위한 경제적인 경로, 특히 종래의 방법과는 다른 록소프로펜의 제조방법을 제공한다. 이 제조방법은 종래 기술에 교시되었거나 그로부터 영감을 받을 수 없다. 이 제조방법은 비교적 저렴한 출발 물질을 취하며, 이는 상업적인 규모의 생산에 적합하다.The present invention provides an economical route to prepare substituted phenylacetic acid derivatives or pharmaceutically acceptable non-toxic salt forms thereof, in particular a method for preparing roxofene, which differs from conventional methods. This method of manufacture cannot be taught or inspired by the prior art. This process takes a relatively inexpensive starting material, which is suitable for commercial scale production.

본 발명은 화학식 F의 화합물을 제공하고, The present invention provides a compound of formula F,

Figure pct00005
Figure pct00005

여기서, 일반식 F는

Figure pct00006
또는
Figure pct00007
이고; G는 CN 또는 COOR2이고, G1은 O, NR6, S 또는 C이고; n은 1 내지 3의 정수이고; R5는 COOR3, CN, OTf, OTs, OMs, 할로겐, OH, CHO, 탄소-탄소 이중 결합 또는 탄소-탄소 삼중 결합이며; R1, R2, R3 및 R6은 각각 독립적으로 수소 또는 저 치환된 알킬기이다.Where the general formula F is
Figure pct00006
or
Figure pct00007
ego; G is CN or COOR 2 and G 1 is O, NR 6 , S or C; n is an integer from 1 to 3; R 5 is COOR 3 , CN, OTf, OTs, OMs, halogen, OH, CHO, carbon-carbon double bond or carbon-carbon triple bond; R 1 , R 2 , R 3 and R 6 are each independently hydrogen or a low substituted alkyl group.

일반식 F의 화합물은 화학식 F-1, 화학식 F-2, 화학식 F-3 또는 화학식 F-4의 화합물일 수 있다.The compound of formula F may be a compound of formula F-1, F-2, F-3 or F-4.

Figure pct00008
Figure pct00008

여기서, G는 CN 또는 COOR2이고, n은 1 내지 3의 정수이고; R1, R2, R3, R6은 각각 독립적으로 수소 또는 저 치환 알킬기이다.Wherein G is CN or COOR 2 and n is an integer from 1 to 3; R 1 , R 2 , R 3 , and R 6 are each independently hydrogen or a low substituted alkyl group.

바람직하게는, 화합물은 화학식 Ⅱ-2, 화학식 Ⅱ-2’, 화학식 Ⅰ-2 또는 화학식 Ⅰ-2’이다.Preferably, the compound is formula II-2, formula II-2 ', formula I-2 or formula I-2'.

Figure pct00009
Figure pct00009

여기서, R1, R2, R3은 각각 독립적으로 수소 또는 저 치환 알킬기이고, n은 1 내지 3의 정수이다.Here, R 1 , R 2 and R 3 are each independently hydrogen or a low substituted alkyl group, and n is an integer of 1 to 3.

본 발명은 고리화 반응(cyalization reaction)에 의해 화학식 II의 화합물로부터 화학식 I의 화합물을 제조하는 방법을 추가로 제공하고, 이 반응은 다음과 같이 반응 1에 나타낸다:The present invention further provides a process for preparing a compound of formula (I) from a compound of formula (II) by a cyclization reaction, which reaction is shown in reaction 1 as follows:

Figure pct00010
Figure pct00010

반응 1Reaction 1

여기서, R은 X 또는

Figure pct00011
이고, R1, R2, R3은 각각 독립적으로 수소 또는 저 치환 알킬기이고; n은 1 내지 3의 정수이고; X는 할로겐, OTf, OTs, OMs, 실릴, 티오알킬 또는 암모니아 알킬이고, 보다 바람직하게는, X는 브로모이다.Where R is X or
Figure pct00011
R 1 , R 2 , and R 3 are each independently hydrogen or a low substituted alkyl group; n is an integer from 1 to 3; X is halogen, OTf, OTs, OMs, silyl, thioalkyl or ammonia alkyl, more preferably X is bromo.

본 발명에서, R5은 OH, CHO, OTf, OTs, Oms, 할로겐, 탄소-탄소 이중 결합 또는 탄소-탄소 삼중 결합의 군으로 화합물을 나타내는 화학식 F의 화합물로 제조된다. 원료(raw material)는 기존의 기술에 따라 화학식 II의 화합물로 전환될 수 있으며, 이어서 후속 반응이 수행될 수 있다.In the present invention, R 5 is prepared from a compound of formula F which represents the compound in the group of OH, CHO, OTf, OTs, Oms, halogen, carbon-carbon double bond or carbon-carbon triple bond. The raw material can be converted to the compound of formula II according to existing techniques, followed by subsequent reactions.

반응 1에 나타낸 바와 같이, 고리화 반응에 의해 일반식 II 화합물로부터 일반식 I 화합물을 얻었다.As shown in reaction 1, the general formula I compound was obtained from the general formula II compound by cyclization reaction.

고리화 반응의 시약은 당분야에서 통상적으로 사용되는 염기일 수 있다. 시약은 제한되지 않으나, 통상적인 무기 염기 또는 알칼리 토금속 수산화물, 또는 약산의 알칼리 금속 염, 또는 다양한 알칼리 금속 알콕시드, 또는 수소화물, 아미드 등, 예컨대 수산화 나트륨, 수산화칼슘, 탄산나트륨, 중탄산칼륨, 인산칼륨, 나트륨 에톡시드, 칼륨 t-부톡사이드, 수소화 나트륨, 수소화 칼슘, 나트륨 아미드 등이다. 동시에, 시약은 제한되지 않으나, 통상적인 유기 염기, 또는 아민, 또는 피리딘, 또는 이미다졸, 또는 피페리딘, 또는 피롤이다.Reagents of the cyclization reaction may be bases commonly used in the art. Reagents include, but are not limited to, conventional inorganic base or alkaline earth metal hydroxides, alkali metal salts of weak acids, or various alkali metal alkoxides, or hydrides, amides and the like, such as sodium hydroxide, calcium hydroxide, sodium carbonate, potassium bicarbonate, potassium phosphate, Sodium ethoxide, potassium t-butoxide, sodium hydride, calcium hydride, sodium amide and the like. At the same time, the reagents are, but are not limited to, conventional organic bases, or amines, or pyridine, or imidazole, or piperidine, or pyrrole.

R이 X이면, 반응은 다음에 나타낸 바와 같다:If R is X, the reaction is as shown below:

Figure pct00012
Figure pct00012

X는 할로겐, OTf, OTs, OMs, 실릴, 티오알킬 또는 암모니아 알킬이고, 더욱 바람직하게는, X는 브로모이고; R3은 알킬기 또는 수소이다.X is halogen, OTf, OTs, OMs, silyl, thioalkyl or ammonia alkyl, more preferably X is bromo; R 3 is an alkyl group or hydrogen.

R이

Figure pct00013
이면, 반응은 다음에 나타낸 바와 같다:R is
Figure pct00013
If so, the reaction is as shown below:

Figure pct00014
Figure pct00014

R1, R2 및 R3의 정의는 위와 동일하다.The definitions of R 1 , R 2 and R 3 are the same as above.

본 발명은 염기에서 고리화 반응에 의해 화학식 Ⅱ-2’의 화합물로부터 화학식 Ⅰ-2’의 화합물을 제조하는 방법을 추가로 제공한다.The present invention further provides a process for preparing a compound of formula I-2 'from a compound of formula II-2' by a cyclization reaction at a base.

Figure pct00015
Figure pct00015

R1, R2는 각각 독립적으로 수소 또는 저 치환 알킬기이고; n은 1 내지 3의 정수이다.R 1 and R 2 are each independently hydrogen or a low substituted alkyl group; n is an integer of 1-3.

본 발명에서, 상기 화학식 Ⅱ-2 및 Ⅰ-2의 화합물은 결합 반응에 의해 각기 화학식 a의 화합물과 반응하는 화학식 Ⅱ-1 및 Ⅰ-1의 화합물로부터 얻을 수 있으며, 반응은 다음에 나타낸 바와 같다:In the present invention, the compounds of the formulas (II-2) and (I-2) can be obtained from the compounds of the formulas (II-1) and (I-1), each of which reacts with the compound of the formula (a) by a coupling reaction, and the reaction is as follows. :

Figure pct00016
Figure pct00016

R1, R2, R3, X 및 n의 정의는 위와 동일하다.The definitions of R 1 , R 2 , R 3 , X and n are the same as above.

화학식 F의 화합물은 결합 반응에 의해 화학식 F’의 화합물로부터 얻을 수 있으며, 반응은 다음에 나타낸 바와 같다:The compound of formula F can be obtained from the compound of formula F 'by a coupling reaction, and the reaction is as follows:

Figure pct00017
Figure pct00017

화학식 F, F’의 E 부분은

Figure pct00018
또는
Figure pct00019
이고; G1은 O, NR6, S또는 C이고; n은 1 내지 3의 정수이고; R5는 COOR3, CN, OTf, OTs, OMs, 할로겐, OH, CHO, 탄소-탄소 이중 결합 또는 탄소-탄소 삼중 결합이고; R1, R2, R3, R6은 각각 독립적으로 수소 또는 저 치환된 알킬기이다. X의 정의는 위와 동일하다.The E part of formula F, F '
Figure pct00018
or
Figure pct00019
ego; G 1 is O, NR 6 , S or C; n is an integer from 1 to 3; R 5 is COOR 3 , CN, OTf, OTs, OMs, halogen, OH, CHO, carbon-carbon double bond or carbon-carbon triple bond; R 1 , R 2 , R 3 and R 6 are each independently hydrogen or a low substituted alkyl group. The definition of X is the same as above.

결합 반응은 촉매의 존재하에 수행한다. 촉매는 니켈, 팔라듐의 화합물 또는 이들 화합물과 리간드의 혼합물이다. 니켈 화합물은 다양한 원자가(valence)를 갖는 Ni의 화합물일 수 있으며, 바람직하게는 니켈 브로마이드 및 니켈 아세틸아세토네이트이다. 팔라듐 화합물은 다양한 원자가, 바람직하게는 팔라듐 디클로라이드 및 테트라키스 트리페닐포스핀 팔라듐을 갖는 Pd의 화합물일 수 있다. 이들 리간드는 2-2’-비피리딘, 테르피리딘, 페난트롤린 또는 그의 유도체, 바람직하게는 2-2’-비피리딘이고; 금속은 Cu, Zn, Fe, Mn, Mg 및 그의 염 등이고, 더욱 바람직하게는 Mn 및 그의 염이다.The coupling reaction is carried out in the presence of a catalyst. The catalyst is a compound of nickel, palladium or a mixture of these compounds and ligands. The nickel compound may be a compound of Ni having various valences, preferably nickel bromide and nickel acetylacetonate. The palladium compound may be a compound of Pd having various valences, preferably palladium dichloride and tetrakis triphenylphosphine palladium. These ligands are 2-2'-bipyridine, terpyridine, phenanthroline or derivatives thereof, preferably 2-2'-bipyridine; The metal is Cu, Zn, Fe, Mn, Mg, salts thereof, and the like, more preferably Mn and salts thereof.

본 발명은 프리델-크래프트 아실화 반응에 의해 염화 아실과 반응하는 치환된 페닐아세트산의 화합물로부터 화합물 Ⅱ-2를 제조하는 다른 방법을 추가로 제공한다.The present invention further provides another method for preparing compound II-2 from the compound of substituted phenylacetic acid reacted with acyl chloride by Friedel-Craft acylation reaction.

Figure pct00020
Figure pct00020

이들 R1, R2, R3, X 및 n의 정의는 위와 동일하다.The definitions of these R 1 , R 2 , R 3 , X and n are the same as above.

또한, 치환된 페닐아세트산과 아디프산 무수물 (n = 1)을 반응시킨 다음, 에스테르화 반응에 의해 알콜과 반응시켜 화합물 Ⅱ-2를 얻는다.Further, substituted phenylacetic acid and adipic anhydride (n = 1) are reacted, followed by reaction with alcohol by esterification to give compound II-2.

Figure pct00021
Figure pct00021

이들 R1, R2, R3, X 및 n의 정의는 위와 동일하다.The definitions of these R 1 , R 2 , R 3 , X and n are the same as above.

알콜은 당분야에서 통상적으로 사용되는 메탄올, 에탄올 등이다.Alcohols are methanol, ethanol and the like commonly used in the art.

화합물 Ⅱ-2의 또 다른 제조방법은 상응하는 카복실산과 반응하는 치환된 페닐아세트산의 화합물로부터 얻는다.Another method for preparing compound II-2 is obtained from a compound of substituted phenylacetic acid which reacts with the corresponding carboxylic acid.

Figure pct00022
Figure pct00022

이들 R1, R2, R3, X 및 n의 정의는 위와 동일하다.The definitions of these R 1 , R 2 , R 3 , X and n are the same as above.

본 발명에서, 화학식 II-1의 화합물은 아디프산 무수물 (n = 1)과 반응한 다음, 에스테르화 반응에 의해 알콜과 반응하는 벤젠 할라이드의 화합물로부터 얻는다.In the present invention, the compound of formula II-1 is obtained from a compound of benzene halide which reacts with adipic anhydride (n = 1) and then with alcohol by esterification reaction.

Figure pct00023
Figure pct00023

X는 할로겐이고, 보다 바람직하게는, X는 브로모이다. R3의 정의는 위와 동일하다.X is halogen, more preferably, X is bromo. The definition of R 3 is the same as above.

알콜은 당분야에서 통상적으로 사용되는 메탄올, 에탄올 등이다.Alcohols are methanol, ethanol and the like commonly used in the art.

또는, 화학식 II-1의 화합물은 염화 아실 반응에 의해 아실 할라이드와 반응하는 벤젠 할라이드로부터 얻는다.Alternatively, the compound of formula (II-1) is obtained from benzene halides which react with acyl halides by acyl chloride reactions.

Figure pct00024
Figure pct00024

X는 할로겐이고, 보다 바람직하게는, X는 브로모이다. R3의 정의는 위와 동일하다.X is halogen, more preferably, X is bromo. The definition of R 3 is the same as above.

화학식 II-1의 화합물은 카복실산 또는 카복실산 에스테르와 반응하는 벤젠 할라이드로부터 얻는다.Compounds of formula (II-1) are obtained from benzene halides which react with carboxylic acids or carboxylic esters.

Figure pct00025
Figure pct00025

X는 할로겐이고, 보다 바람직하게는, X는 브로모이다. R3의 정의는 위와 동일하다.X is halogen, more preferably, X is bromo. The definition of R 3 is the same as above.

본 발명은 카보닐기의 환원에 의해 화학식 Ⅰ-2의 화합물로부터 치환된 페닐아세트산의 화합물을 제조하는 방법을 추가로 제공한다.The present invention further provides a process for preparing a compound of substituted phenylacetic acid from a compound of formula (I-2) by reduction of a carbonyl group.

Figure pct00026
Figure pct00026

R1, R2는 독립적으로 수소 또는 저 치환 알킬기이고, n은 1 내지 3의 정수이다.R 1 and R 2 are independently hydrogen or a low substituted alkyl group, and n is an integer of 1 to 3.

본 발명의 또 다른 측면에 따르면, 본 발명은 가수분해 반응에 의해 산 또는 염기와 반응한 다음, 카보닐기의 환원에 의해 화학식 Ⅰ-2’의 화합물로부터 치환된 페닐아세트산 화합물을 제조하는 방법을 제공한다.According to another aspect of the present invention, the present invention provides a method for preparing a substituted phenylacetic acid compound from a compound of formula I-2 'by reacting with an acid or a base by a hydrolysis reaction and then by reduction of a carbonyl group. do.

Figure pct00027
Figure pct00027

R1 및 R2는 독립적으로 수소 또는 저 치환 알킬기이다. n은 1 내지 3의 정수이다.R 1 and R 2 are independently hydrogen or a low substituted alkyl group. n is an integer of 1-3.

환원제는 팔라듐 탄소/수소, 레이니-니켈(raney-nickel), 붕소 환원제, 알루미늄 환원제, 금속 철 분말, 아연 분말, Zn-Hg 또는 히드라진 수화물 등의 당분야에서 통상적으로 사용되는 환원제이다.The reducing agent is a reducing agent commonly used in the art, such as palladium carbon / hydrogen, raney-nickel, boron reducing agent, aluminum reducing agent, metal iron powder, zinc powder, Zn-Hg or hydrazine hydrate.

n이 1이면, R1은 메틸이고, R2는 수소이며, 치환된 페닐아세트산 화합물은 록소프로펜이다. 록소프로펜 나트륨은 수산화 나트륨과 반응하는 록소프로펜 같이, 공지된 방법을 사용하여 당분야의 기술자가 이용가능하다.If n is 1, R 1 is methyl, R 2 is hydrogen, and the substituted phenylacetic acid compound is loxopropene. Roxopropene sodium is available to those skilled in the art using known methods, such as roxofene, which reacts with sodium hydroxide.

본 발명과 관련된 반응은 다음과 같이 방정식 도해로 표시할 수 있다.The reaction associated with the present invention can be represented by the equation diagram as follows.

Figure pct00028
Figure pct00028

여기서, X는 할로겐이고; R1, R2, R3은 수소 또는 저 치환 알킬기이고; n은 0, 1, 2, 3 등의 정수 형태이다. 보다 바람직하게는, n은 1이고, R1은 메틸이고, R2는 수소이고, X는 브롬이다.Wherein X is halogen; R 1 , R 2 , R 3 are hydrogen or a low substituted alkyl group; n is an integer form, such as 0, 1, 2, 3. More preferably, n is 1, R 1 is methyl, R 2 is hydrogen and X is bromine.

본 발명에서 제공하는 제조방법은 다음과 같은 유리한 효과를 갖는다. 먼저, 본 발명은 치환된 페닐아세트산 유도체를 제조하는 대안적인 방법을 제공한다. 둘째, 본 발명의 제조방법은 종래 기술에 의해 교시되지 않았다. 셋째, 출발 원료로서 벤젠프로판산, 아디프산 무수물 및 아디프산을 반응에 사용할 경우, 가격이 저렴하며 구하기 쉽다. 넷째, 본 발명서 제공하는 제조방법은 산업적인 대규모 생산에 적합하며, 특정한 경제적 이점을 갖는다.The manufacturing method provided by the present invention has the following advantageous effects. First, the present invention provides an alternative method for preparing substituted phenylacetic acid derivatives. Second, the manufacturing method of the present invention has not been taught by the prior art. Third, when benzene propanoic acid, adipic anhydride and adipic acid are used in the reaction as starting materials, the price is low and easy to obtain. Fourth, the manufacturing method provided by the present invention is suitable for large scale industrial production, and has certain economic advantages.

Figure pct00029
Figure pct00029

디클로로메탄 (1.1kg, 7w)과 무수 삼염화 알루미늄 (333.4g, 2.5몰)을 3L의 반응 용기에 첨가하고 가열 및 환류시켰다. 다음에, 아디프산 무수물 (470g의 디클로로메탄에 용해한 140.8g)을 반응 혼합물에 적가하였다. 아디프산의 탈수에 의해 아디프산 무수물을 제조하고, 온도를 2-3 시간 유지하면서 적가를 종료하였다. 브롬 벤젠 (157g, 1 몰)을 환류 상태로 반응 혼합물에 적가하고, 첨가 후 3-5 시간에 샘플을 채취해서, 0.5% 미만의 HPLC로 원료를 검출하였다. 3-4 시간 동안 온도를 유지하면서 메탄올 (160g, 5몰)을 적가한 다음, 반응이 완료될 때까지 HPLC로 이를 검출하였다. 실온까지 냉각하고, 반응 혼합물을 충분히 교반하면서 분쇄한 얼음 (1.78㎏, 10w)에 첨가하여 유기상을 얻었고, 디클로로메탄 (178g×2)으로 수성상을 추출한 다음, 유기상을 합해서 5%의 중탄산 나트륨 (356g, 2W) 용액으로 세척하였다. 다음에, 이를 농축시켜 n-헵탄 (356g, 2W)으로 걸쭉하게 만들고 황색 고체 A-5를 얻은 후, 흡인 여과를 수행하고, 40-45℃의 진공 오븐에서 10-16 시간 동안 건조시켰다. 마지막으로, 백색 고체 II-1 (253.0g)을 84.6% (HPLC 순도 98.1%)로 얻었다.Dichloromethane (1.1 kg, 7 w) and anhydrous aluminum trichloride (333.4 g, 2.5 moles) were added to a 3 L reaction vessel and heated and refluxed. Next, adipic anhydride (140.8 g dissolved in 470 g of dichloromethane) was added dropwise to the reaction mixture. Adipic anhydride was produced by dehydration of adipic acid, and the dropwise addition was terminated while maintaining the temperature for 2-3 hours. Bromine benzene (157 g, 1 mole) was added dropwise to the reaction mixture at reflux, and samples were taken 3-5 hours after addition, and raw materials were detected by less than 0.5% HPLC. Methanol (160 g, 5 moles) was added dropwise while maintaining the temperature for 3-4 hours and then detected by HPLC until the reaction was complete. Cool to room temperature and add the reaction mixture to crushed ice (1.78 kg, 10 w) with sufficient stirring to give an organic phase, extract the aqueous phase with dichloromethane (178 g × 2), and combine the organic phases with 5% sodium bicarbonate ( 356 g, 2W) solution. It was then concentrated to thicken with n-heptane (356 g, 2W) to give a yellow solid A-5, followed by suction filtration and dried in a vacuum oven at 40-45 ° C. for 10-16 hours. Finally, white solid II-1 (253.0 g) was obtained with 84.6% (HPLC purity 98.1%).

Figure pct00030
Figure pct00030

디클로로메탄 (1.1kg, 7w)과 무수 삼염화 알루미늄 (333.4g, 2.5몰)을 3L의 반응 용기에 첨가하고 가열 및 환류시켰다. 다음에, 아디프산 무수물 (470g의 디클로로메탄에 용해한 140.8g)을 반응 혼합물에 적가하였다. 아디프산의 탈수에 의해 아디프산 무수물을 제조하고, 온도를 2-3 시간 유지하면서 적가를 종료하였다. 2-페닐 에틸 프로피오네이트 (178g, 1 몰)를 환류 상태로 반응 혼합물에 적가하고, 첨가 후 3-5 시간에 샘플을 채취해서, 0.5% 미만의 HPLC로 원료를 검출하였다. 3-5 시간 동안 온도를 유지하면서 메탄올 (160g, 5몰)을 적가한 다음, 반응이 완료될 때까지 HPLC로 이를 검출하였다. 실온까지 냉각하고, 반응 혼합물을 충분히 교반하면서 분쇄한 얼음 (1.78㎏, 10w)에 첨가하여 유기상을 얻었고, 디클로로메탄 (178g×2)으로 수성상을 추출한 다음, 유기상을 합해서 5%의 중탄산 나트륨 (356g, 2W) 용액으로 세척하였다. 다음에, 이를 농축시켜 n-헵탄 (356g, 2W)으로 걸쭉하게 만들고 황색 고체 A-5를 얻은 후, 흡인 여과를 수행하고, 40-45℃의 진공 오븐에서 10-16 시간 동안 건조시켰다. 마지막으로, 백색 고체 II-2 (271.3g)를 수율 84.8% (HPLC 순도 98.4%)로 얻었다.Dichloromethane (1.1 kg, 7 w) and anhydrous aluminum trichloride (333.4 g, 2.5 moles) were added to a 3 L reaction vessel and heated and refluxed. Next, adipic anhydride (140.8 g dissolved in 470 g of dichloromethane) was added dropwise to the reaction mixture. Adipic anhydride was produced by dehydration of adipic acid, and the dropwise addition was terminated while maintaining the temperature for 2-3 hours. 2-phenyl ethyl propionate (178 g, 1 mole) was added dropwise to the reaction mixture at reflux, and samples were taken 3-5 hours after addition, and raw materials were detected by less than 0.5% HPLC. Methanol (160 g, 5 moles) was added dropwise while maintaining the temperature for 3-5 hours and then detected by HPLC until the reaction was complete. Cool to room temperature and add the reaction mixture to crushed ice (1.78 kg, 10 w) with sufficient stirring to give an organic phase, extract the aqueous phase with dichloromethane (178 g × 2), and combine the organic phases with 5% sodium bicarbonate ( 356 g, 2W) solution. It was then concentrated to thicken with n-heptane (356 g, 2W) to give a yellow solid A-5, followed by suction filtration and dried in a vacuum oven at 40-45 ° C. for 10-16 hours. Finally, white solid II-2 (271.3 g) was obtained with a yield of 84.8% (HPLC purity 98.4%).

Figure pct00031
Figure pct00031

아디프산 모노메틸 에스테르 (16.00kg)를 30L의 건조 반응 용기에 첨가하고, 10-25℃로 온도를 제어하면서 염화 티오닐을 적가 (11.30kg, 0.95 당량)하고, 약 5 시간 후에 적가를 종료한 다음, 에탄올 유도체화를 검출하면서 실온에서 2 시간 동안 교반하였다. 반응이 종료된 후, 반응 혼합물을 25-30℃의 회전 증발기 수조로 농축시켰다. 다음에, 오일을 얻었고, 디클로로메탄 (5kg)으로 건조시켜 화합물 A-4 (16.02kg, 수율 90.0%, GC 92.8%)를 얻었다.Adipic acid monomethyl ester (16.00 kg) was added to a 30 L dry reaction vessel, thionyl chloride was added dropwise (11.30 kg, 0.95 equiv) while controlling the temperature at 10-25 ° C., and the dropwise addition was terminated after about 5 hours. It was then stirred for 2 hours at room temperature while detecting ethanol derivatization. After the reaction was completed, the reaction mixture was concentrated in a 25-30 ° C. rotary evaporator bath. An oil was then obtained, dried over dichloromethane (5 kg) to afford compound A-4 (16.02 kg, yield 90.0%, GC 92.8%).

Figure pct00032
Figure pct00032

디클로로메탄 (8.8kg)과 무수 염화 알루미늄 (3.0kg)을 20-40℃의 온도에서 30L의 반응 용기에 첨가하였다. 다음에, 적가를 종료한 후 온도를 2 시간 동안 유지하면서 화합물 A-4 (2.35㎏)를 반응 혼합물에 적가하였다. 브롬 벤젠 (1.76kg)을 반응 혼합물에 적가하고 0.5 시간 후에 종료한 후, 온도를 20-25℃에서 10-14 시간 동안 유지하면서 무수 염화 알루미늄 (3.0kg)을 첨가한 다음, 반응이 완료될 때가지 HPLC로 이를 검출하였다. 분쇄한 얼음을 첨가하여 온도를 30℃ 미만으로 제어하면서 반응 혼합물을 분쇄한 얼음 (20kg)에 첨가하였가. 유기상을 얻었고, 디클로로메탄 (1Kg×2)으로 수성상을 추출한 다음, 유기상을 합해서 5%의 중탄산 나트륨 용액으로 세척하고 무수 황산나트륨으로 건조시켰다. 다음에, 이를 농축시켜 미정제 생성물 (3.1 Kg)을 얻었고, 20-40℃에서 1 시간 동안 n-헵탄 (3.5 Kg)으로 걸쭉하게 만들고 흡입 여과한 후, n-헵탄 (2.0 Kg×2)으로 세척하였다. 얻은 고체를 40-45℃의 진공 오븐에서 10-16 시간 동안 건조시켰다. 마지막으로, 화학식 Ⅱ-1의 화합물 (2.95 Kg)을 88%의 수율 (HPLC 순도 97.6%)로 얻었다.Dichloromethane (8.8 kg) and anhydrous aluminum chloride (3.0 kg) were added to a 30 L reaction vessel at a temperature of 20-40 ° C. Next, after completion of the dropwise addition, Compound A-4 (2.35 kg) was added dropwise to the reaction mixture while maintaining the temperature for 2 hours. Bromine benzene (1.76 kg) was added dropwise to the reaction mixture and terminated after 0.5 hours, then anhydrous aluminum chloride (3.0 kg) was added while maintaining the temperature at 20-25 ° C. for 10-14 hours, and then the reaction was completed. This was detected by HPLC. The reaction mixture was added to crushed ice (20 kg) while adding crushed ice to control the temperature below 30 ° C. The organic phase was obtained and the aqueous phase was extracted with dichloromethane (1Kg × 2), then the combined organic phases were washed with 5% sodium bicarbonate solution and dried over anhydrous sodium sulfate. Then it was concentrated to give crude product (3.1 Kg), thickened with n-heptane (3.5 Kg) for 1 hour at 20-40 ° C. and filtered by suction, then n-heptane (2.0 Kg × 2) Washed. The solid obtained was dried in a vacuum oven at 40-45 ° C. for 10-16 hours. Finally, the compound of formula II-1 (2.95 Kg) was obtained in 88% yield (HPLC purity 97.6%).

Figure pct00033
Figure pct00033

디클로로메탄 (800g)과 무수 염화 알루미늄 (200g)을 20-40℃의 온도에서 2L의 반응 용기에 첨가하였다. 다음에, 적가를 종료한 후 온도를 2 시간 동안 유지하면서 화합물 A-4 (195.8g)를 반응 혼합물에 적가하였다. 2-페닐 에틸 프로피오네이트 (178g)를 반응 혼합물에 적가하고 0.5 시간 후에 종료한 후, 온도를 20-25℃에서 10-14 시간 유지하면서 무수 염화 알루미늄 (60g)을 첨가한 다음, 반응이 완료될 때까지 HPLC로 검출하였다. 분쇄한 얼음을 첨가하여 온도를 30℃ 미만으로 조절하면서 분쇄한 얼음 (500g)에 반응 혼합물을 첨가하였다. 유기상을 얻었고, 디클로로메탄 (100g×2)으로 수성상을 추출한 다음, 유기상을 합해서 5%의 중탄산 나트륨 용액으로 세척하고 무수 황산나트륨으로 건조시켰다. 다음에, 이를 농축시켜 미정제 생성물 (310g)을 얻었고, n-헵탄 (200g)으로 20-40℃에서 1 시간 동안 걸쭉하게 만들고, 흡인 여과를 수행한 후, n-헵탄 (100g×2)으로 세척하였다. 얻은 고체를 40-45℃의 진공 오븐에서 10-16 시간 동안 건조시켰다. 마지막으로, 화학식 Ⅱ-2의 화합물 (283.5g)을 88.6%의 수율 (HPLC 순도 > 97.8%)로 얻었다.Dichloromethane (800 g) and anhydrous aluminum chloride (200 g) were added to a 2 L reaction vessel at a temperature of 20-40 ° C. Next, after completion of the dropwise addition, Compound A-4 (195.8 g) was added dropwise to the reaction mixture while maintaining the temperature for 2 hours. 2-phenyl ethyl propionate (178 g) was added dropwise to the reaction mixture and terminated after 0.5 hour, then anhydrous aluminum chloride (60 g) was added while maintaining the temperature at 20-25 ° C. for 10-14 hours, and then the reaction was completed. HPLC was detected until The reaction mixture was added to the crushed ice (500 g) while adding crushed ice to adjust the temperature to below 30 ° C. An organic phase was obtained and the aqueous phase was extracted with dichloromethane (100 g × 2), then the combined organic phases were washed with 5% sodium bicarbonate solution and dried over anhydrous sodium sulfate. Then it was concentrated to give crude product (310 g), thickened with n-heptane (200 g) at 20-40 ° C. for 1 hour, subjected to suction filtration, and then with n-heptane (100 g × 2) Washed. The solid obtained was dried in a vacuum oven at 40-45 ° C. for 10-16 hours. Finally, compound (283.5 g) of formula II-2 was obtained in a yield of 88.6% (HPLC purity> 97.8%).

Figure pct00034
Figure pct00034

온도를 상승시켜 환류하고 온도를 3-4 시간 동안 유지하면서 톨루엔 (100g), 화합물 II-1 (29.9g) 및 나트륨 아미드 (3.9g)를 1L의 반응 용기에 첨가하고, 0.2% 미만의 HPLC로 원료를 검출하였다. 실온까지 냉각하고, 여과를 통해 여액을 얻었고, 아세트산을 첨가하여 pH = 6으로 조정하고, 5%의 중탄산 나트륨 용액 (50g×3)으로 세척하였다. 다음에, 이를 농축시켜 미정제 생성물 (310g)을 얻었고, n-헵탄으로 걸쭉하게 만들고 흡인 여과를 수행한 후, n-헵탄으로 세척하였다. 얻은 고체를 40-45℃의 진공 오븐에서 10-16 시간 동안 건조시켰다. 마지막으로, 백색 고체 I-1 (24.5g)을 92.0%의 수율 (HPLC 순도 98.1%)로 얻었다.Toluene (100 g), Compound II-1 (29.9 g) and sodium amide (3.9 g) were added to a 1 L reaction vessel while raising the temperature to reflux and maintaining the temperature for 3-4 hours, with less than 0.2% HPLC Raw material was detected. Cool to room temperature, filter to obtain filtrate, adjust to pH = 6 by adding acetic acid and wash with 5% sodium bicarbonate solution (50 g × 3). Then it was concentrated to give crude product (310 g), thickened with n-heptane and subjected to suction filtration, followed by washing with n-heptane. The solid obtained was dried in a vacuum oven at 40-45 ° C. for 10-16 hours. Finally, white solid I-1 (24.5 g) was obtained with a yield of 92.0% (HPLC purity 98.1%).

Figure pct00035
Figure pct00035

N-N’-디메틸 포름아미드 (100g), 브롬화 니켈 (1.53g), 2-2’-비피리딜 (1.09g), 망간 분말 (6.05g) 및 트리플루오로 아세트산 (0.034g)을 250㎖의 반응 용기에 첨가하고, 80-85℃의 온도까지 가열하였다. 다음에, 화합물 Ⅱ-1 (13.66g의 2-클로로프로피온산 에틸 에스테르에 용해한 29.9g)을 반응 혼합물에 적가한 다음, 적가를 종료한 후 30 분 동안 온도를 유지하고, 0.2% 미만의 HPLC로 원료를 검출하였다. 실온까지 냉각하고, 1N의 염산을 첨가하여 pH = 6으로 조절하고, EA (100g×2)로 추출한 다음, 유기상을 합해서 5%의 중탄산 나트륨 용액 (30g)으로 세척하였다. 다음에, 이를 농축시켜 미정제 생성물을 얻은 다음, 고진공 증류에 의해 26.33g의 화합물 II-2를 82.3%의 수율 (HPLC 순도 > 99.2%)로 얻었다.250 ml of N-N'-dimethyl formamide (100 g), nickel bromide (1.53 g), 2-2'-bipyridyl (1.09 g), manganese powder (6.05 g) and trifluoro acetic acid (0.034 g) Was added to the reaction vessel of and heated to a temperature of 80-85 ° C. Next, Compound II-1 (29.9 g dissolved in 13.66 g of 2-chloropropionic acid ethyl ester) was added dropwise to the reaction mixture, and then the temperature was maintained for 30 minutes after completion of the dropwise addition, followed by HPLC of less than 0.2%. Was detected. Cooled to room temperature, adjusted to pH = 6 by adding 1N hydrochloric acid, extracted with EA (100 g × 2), and then combined the organic phases and washed with 5% sodium bicarbonate solution (30 g). This was then concentrated to give crude product, which was then subjected to high vacuum distillation to give 26.33 g of compound II-2 in 82.3% yield (HPLC purity> 99.2%).

Figure pct00036
Figure pct00036

온도를 상승시켜 환류하고 다량의 가스 방출 (암모니아)에 의해 온도를 2 시간 동안 유지하면서 톨루엔 (960g, 3w), 화합물 II-2 (320.4g, 1 몰) 및 나트륨 아미드 (39g, 1.0 몰)를 3L의 반응 용기에 첨가하였다. 다음에, 계(system)는 점성이 되었고, 반응 혼합물을 2 시간 동안 그 온도에서 연속으로 반응시킨 후, 계는 점차 얇아졌다. 4 시간 반응 후, 0.5% 미만의 HPLC로 원료를 검출하였다. 실온까지 냉각하고, 아세트산을 첨가하여 pH = 6으로 조절한 다음, 여과하고 여액을 5%의 중탄산 나트륨 용액 (320g×3)으로 세척하고, 유기상을 농축시켜 미정제 생성물을 얻은 다음, n-헵탄 (640g, 2W)으로 흡입 여과를 수행하였다. 얻은 고체를 40-45℃의 진공 오븐에서 10-16 시간 동안 건조시켰다. 마지막으로, 백색 고체 I-2 (267.0g)를 92.6%의 수율 (HPLC 순도 > 98.2%)로 얻었다.Toluene (960 g, 3w), compound II-2 (320.4 g, 1 mole) and sodium amide (39 g, 1.0 mole) were added to reflux by raising the temperature to reflux and maintaining the temperature for 2 hours by a large amount of gas evolution (ammonia). It was added to 3 L of reaction vessel. The system then became viscous and after reacting the reaction mixture continuously at that temperature for 2 hours, the system gradually became thinner. After 4 hours reaction, the raw material was detected by less than 0.5% HPLC. Cool to room temperature, adjust acetic acid to pH = 6, filter, wash the filtrate with 5% sodium bicarbonate solution (320g × 3), concentrate the organic phase to give crude product, then n-heptane Suction filtration was performed at (640 g, 2 W). The solid obtained was dried in a vacuum oven at 40-45 ° C. for 10-16 hours. Finally, white solid I-2 (267.0 g) was obtained in a yield of 92.6% (HPLC purity> 98.2%).

Figure pct00037
Figure pct00037

N-N’-디메틸 포름아미드 (100g), 브롬화 니켈 (1.53g), 2-2’-비피리딜 (1.09g), 망간 분말 (6.05g) 및 트리플루오로 아세트산 (0.034g)을 250㎖의 반응 용기에 첨가하고, 80-85℃의 온도로 가열하였다. 다음에, 화합물 I-1 (13.66g의 2-클로로프로피온산 에틸 에스테르에 용해한 29.9g)을 반응 혼합물에 적가한 다음, 적가를 종료한 후 30 분 동안 온도를 유지하고, 0.2% 미만의 HPLC로 원료를 검출하였다. 실온까지 냉각하고, 1N의 염산을 첨가하여 pH = 6으로 조절하고, EA (100g×2)로 추출한 다음, 유기상을 합해서 5%의 중탄산 나트륨 용액 (30g)으로 세척하였다. 다음에, 이를 농축시켜 미정제 생성물을 얻은 다음, 고진공 증류에 의해 26.33g의 화합물 I-2를 82.3%의 수율 (HPLC 순도 > 99.2%)로 얻었다.250 ml of N-N'-dimethyl formamide (100 g), nickel bromide (1.53 g), 2-2'-bipyridyl (1.09 g), manganese powder (6.05 g) and trifluoro acetic acid (0.034 g) Was added to the reaction vessel and heated to a temperature of 80-85 ° C. Next, Compound I-1 (29.9 g dissolved in 13.66 g of 2-chloropropionic acid ethyl ester) was added dropwise to the reaction mixture, after which the dropping was completed, the temperature was maintained for 30 minutes, and the raw material was less than 0.2% HPLC. Was detected. Cooled to room temperature, adjusted to pH = 6 by adding 1N hydrochloric acid, extracted with EA (100 g × 2), and then combined the organic phases and washed with 5% sodium bicarbonate solution (30 g). This was then concentrated to give crude product, which was then subjected to high vacuum distillation to give 26.33 g of compound I-2 in 82.3% yield (HPLC purity> 99.2%).

Figure pct00038
Figure pct00038

이소프로판올 (1.5kg), 화합물 I-2 (576.7g, 2몰) 및 팔라듐 탄소 (28.8g)를 1.2-1.4㎫ 및 100-110℃의 온도에서 2 시간 동안 환기하의 H2분위기에서 3L 오토클레이브에 첨가하고, 원료를 0.5% 미만의 HPLC로 검출하였다. 실온까지 냉각하고, 반응 혼합물을 여과한 후, 이소프로판올 (200g)로 세척하였다. 다음에, 이를 농축시켜 오일 화합물 I-3의 미정제 생성물 (539.9g)을 수율 98.4% (HPLC 순도 98.1%)로 얻었다.Isopropanol (1.5 kg), Compound I-2 (576.7 g, 2 mol) and palladium carbon (28.8 g) were added to a 3L autoclave in H 2 atmosphere under ventilation for 2 hours at a temperature of 1.2-1.4 MPa and 100-110 ° C. The raw material was added and detected by less than 0.5% HPLC. After cooling to room temperature, the reaction mixture was filtered and washed with isopropanol (200 g). Then it was concentrated to give crude product (539.9 g) of oil compound I-3 in yield 98.4% (HPLC purity 98.1%).

Figure pct00039
Figure pct00039

메탄올 (1㎏), 화합물 II-2’ (287.3g, 1 몰) 및 나트륨 메톡사이드 고체 (81g, 1.5 몰)를 3L의 반응 용기에 첨가하고, 온도를 유지하면서 3 시간 동안 가열하여 환류시켰다. 반응이 완료된 후, 실온까지 냉각하고, 농축시켰다. 얻은 잔류물을 에틸 아세테이트 (300g)에 용해시키고, 물 (50g)로 세척한 후, 건조 및 농축시켜 화합물 I-2’ (283.2g)를 수율 98.6% (HPLC 순도 98.7%)로 얻었다.Methanol (1 kg), Compound II-2 '(287.3 g, 1 mol) and sodium methoxide solid (81 g, 1.5 mol) were added to a 3 L reaction vessel and heated to reflux for 3 hours while maintaining the temperature. After the reaction was completed, it was cooled to room temperature and concentrated. The obtained residue was dissolved in ethyl acetate (300 g), washed with water (50 g), dried and concentrated to give compound I-2 '(283.2 g) in yield 98.6% (HPLC purity 98.7%).

Figure pct00040
Figure pct00040

10% 염산 (1Kg) 및 화합물 I-2’ (283.2g)를 3L의 반응 용기에 첨가하고, 50-55℃로 가열한 후 온도를 3 시간 동안 유지하였다. 반응이 종료된 후 실온까지 냉각하고, 아세트산 에틸 (300g)로 추출하여, 수상(water phase)을 아세트산 에틸로 1 회 추출하였다. 유기상을 합해서, 건조시키고 농축시켜 화합물 I-2 (266.1g)를 수율 98.4% (HPLC 순도 98.7%)로 얻었다.10% hydrochloric acid (1Kg) and compound I-2 '(283.2g) were added to a 3L reaction vessel and heated to 50-55 ° C and the temperature was maintained for 3 hours. After the reaction was completed, the mixture was cooled to room temperature, extracted with ethyl acetate (300 g), and the water phase was extracted once with ethyl acetate. The organic phases were combined, dried and concentrated to give compound I-2 (266.1 g) in yield 98.4% (HPLC purity 98.7%).

이소프로판올 (1.5kg), 화합물 I-2 (266.1g) 및 팔라듐 탄소 (28.8g)를 1.2-1.4㎫ 및 100-110℃의 온도에서 2 시간 동안 환기하의 H2분위기에서 3L 오토클레이브에 첨가하고, 미가공 물질을 0.5% 미만의 HPLC로 검출하였다. 실온까지 냉각하고, 반응 혼합물을 여과한 후, 이소프로판올 (200g)로 세척하였다. 다음에, 이를 농축시켜 오일 화합물 I-3의 미정제 생성물 (248.1g)을 수율 98% (HPLC 순도 98.3%)로 얻었다.Isopropanol (1.5 kg), Compound I-2 (266.1 g) and palladium carbon (28.8 g) are added to a 3L autoclave in H 2 atmosphere under ventilation at a temperature of 1.2-1.4 MPa and 100-110 ° C. for 2 hours, Raw material was detected by less than 0.5% HPLC. After cooling to room temperature, the reaction mixture was filtered and washed with isopropanol (200 g). Then it was concentrated to give crude product (248.1 g) of oil compound I-3 in yield 98% (HPLC purity 98.3%).

Claims (11)

다음에 나타낸 바와 같은 구조를 갖는 일반식 F의 화합물:
Figure pct00041

여기서, 일반식 F의 E부분은
Figure pct00042
또는
Figure pct00043
이고; G는 CN 또는 COOR2이고, G1은 O, NR6, S또는 C이고; n은 1 내지 3의 정수이고; R5는 COOR3, CN, OTf, OTs, OMs, 할로겐, OH, CHO, 탄소-탄소 이중 결합 또는 탄소-탄소 삼중 결합이며; R1, R2, R3 및 R6은 각각 독립적으로 수소 또는 저 치환된 알킬기이다.
A compound of formula F having the structure as shown below:
Figure pct00041

Here, the E part of general formula F
Figure pct00042
or
Figure pct00043
ego; G is CN or COOR 2 and G 1 is O, NR 6 , S or C; n is an integer from 1 to 3; R 5 is COOR 3 , CN, OTf, OTs, OMs, halogen, OH, CHO, carbon-carbon double bond or carbon-carbon triple bond; R 1 , R 2 , R 3 and R 6 are each independently hydrogen or a low substituted alkyl group.
제 1 항에 있어서, 화학식 F-1, 화학식 F-2, 화학식 F-3 또는 화학식 F-4의 화합물인 일반식 화합물:
Figure pct00044

여기서, G는 CN 또는 COOR2이고, n은 1 내지 3의 정수이고; R1, R2, R3, R6은 각각 독립적으로 수소 또는 저 치환 알킬기이다.
The compound of claim 1, wherein the compound is a compound of Formula F-1, Formula F-2, Formula F-3, or Formula F-4:
Figure pct00044

Wherein G is CN or COOR 2 and n is an integer from 1 to 3; R 1 , R 2 , R 3 , and R 6 are each independently hydrogen or a low substituted alkyl group.
제 1 항에 있어서, 화학식 Ⅱ-2, 화학식 Ⅱ-2’, 화학식 Ⅰ-2 또는 화학식 Ⅰ-2’의 화합물인 일반식 화합물:
Figure pct00045

여기서, R1, R2 및 R3은 독립적으로 수소 또는 저 치환 알킬기이고, n은 1 내지 3의 정수이다.
The compound of claim 1, wherein the compound is a compound of Formula II-2, Formula II-2 ′, Formula I-2 or Formula I-2 ′:
Figure pct00045

Wherein R 1 , R 2 and R 3 are independently hydrogen or a low substituted alkyl group, and n is an integer from 1 to 3.
화학식 II의 화합물로부터 고리화 반응을 통해 얻는, 화학식 I의 화합물의 제조방법:
Figure pct00046

여기서, R은 X 또는
Figure pct00047
이고, R1, R2 및 R3은 독립적으로 수소 또는 저 치환 알킬기이고, n은 1 내지 3의 정수이고; X는 할로겐, OTf, OTs, OMs, 실릴, 티오알킬 또는 암모니아 알킬이다.
Process for the preparation of compounds of formula (I), obtained via cyclization from compounds of formula (II):
Figure pct00046

Where R is X or
Figure pct00047
R 1 , R 2 and R 3 are independently hydrogen or a low substituted alkyl group, n is an integer from 1 to 3; X is halogen, OTf, OTs, OMs, silyl, thioalkyl or ammonia alkyl.
화학식 Ⅱ-2’의 화합물로부터 염기에서의 고리화 반응을 통해 얻는, 제 3 항에 따른 화학식 Ⅰ-2’의 화합물의 제조방법:
Figure pct00048

여기서, R1, R2는 독립적으로 수소 원자 또는 저 치환 알킬기이고, n은 1 내지 3의 정수이다.
Process for the preparation of the compound of formula I-2 'according to claim 3, obtained through a cyclization reaction in a base from the compound of formula II-2':
Figure pct00048

Here, R <1> , R <2> is a hydrogen atom or a low substituted alkyl group independently, n is an integer of 1-3.
화학식 F’의 화합물 및 화학식 a의 화합물에 의해 결합 반응을 통해 얻는, 제 1 항에 따른 화학식 F의 화합물의 제조방법:
Figure pct00049

여기서, 일반식 F, F’의 E부분은
Figure pct00050
또는
Figure pct00051
이고; G1은 O, NR6, S 또는 C이고; n은 1 내지 3의 정수이고; R5는 COOR3, CN, OTf, OTs, OMs, 할로겐, OH, CHO, 탄소-탄소 이중 결합 또는 탄소-탄소 삼중 결합이며; R1, R2, R3 및 R6은 각각 독립적으로 수소 또는 저 치환된 알킬기이고, X는 할로겐, OTf, OTs, OMs, 실릴, 티오알킬 또는 암모니아 알킬이다.
A process for preparing a compound of formula F according to claim 1, obtained through a coupling reaction with a compound of formula F ′ and a compound of formula a:
Figure pct00049

Here, the E portion of the general formula F, F '
Figure pct00050
or
Figure pct00051
ego; G 1 is O, NR 6 , S or C; n is an integer from 1 to 3; R 5 is COOR 3 , CN, OTf, OTs, OMs, halogen, OH, CHO, carbon-carbon double bond or carbon-carbon triple bond; R 1 , R 2 , R 3 and R 6 are each independently hydrogen or a low substituted alkyl group and X is halogen, OTf, OTs, OMs, silyl, thioalkyl or ammonia alkyl.
프리델-크래프츠 반응(Friedel-Crafts reaction)을 통해 얻고, 반응은 다음에 나타낸 바와 같은, 제 3 항에 따른 화학식 Ⅱ-2, 화학식 Ⅱ-1의 화합물의 제조방법:
Figure pct00052

Figure pct00053

여기서, R1, R2 및 R3은 각각 독립적으로 수소 또는 저 치환 알킬기이고, n은 1 내지 3의 정수이며; X는 할로겐, OTf, OTs, OMs, 실릴, 티오알킬 또는 암모니아 알킬이다.
Obtained through a Friedel-Crafts reaction, the reaction is prepared by the process of the compounds of formulas II-2 and II-1 according to claim 3, as shown below:
Figure pct00052

Figure pct00053

Wherein R 1 , R 2 and R 3 are each independently hydrogen or a low substituted alkyl group, n is an integer from 1 to 3; X is halogen, OTf, OTs, OMs, silyl, thioalkyl or ammonia alkyl.
제 3 항의 화학식 Ⅰ-2의 화합물로부터 카보닐 환원을 통해, 또는 화학식 Ⅰ-2’의 화합물로부터 가수분해 반응, 및 이어서 카보닐 환원을 통해 얻는, 치환된 페닐아세트산의 제조방법:
Figure pct00054

여기서, R1 및 R2는 각각 수소 또는 저 치환 알킬기이고, n은 1 내지 3의 정수이다.
A process for the preparation of substituted phenylacetic acid, obtained via carbonyl reduction from the compound of formula I-2 of claim 3 or through hydrolysis reaction from a compound of formula I-2 ', followed by carbonyl reduction.
Figure pct00054

Wherein R 1 and R 2 are each hydrogen or a low substituted alkyl group, and n is an integer of 1 to 3;
제 4 항 또는 제 5 항에 있어서, 고리화 반응은 염기의 존재하에 수행하고, 염기는 유기 염기, 무기 염기 또는 약산의 알칼리 토금속 염, 알칼리 금속 알콜레이트, 수소화물 또는 암모니아화물인 제조방법.The process according to claim 4 or 5, wherein the cyclization reaction is carried out in the presence of a base and the base is an alkaline earth metal salt, an alkali metal alcoholate, a hydride or an ammonia of an organic base, an inorganic base or a weak acid. 제 6 항에 있어서, 결합 반응은 촉매, 금속 또는 금속 염의 존재하에 수행하고, 촉매는 니켈 화합물, 팔라듐 화합물 또는 리간드와의 그의 혼합물이며, 금속 또는 금속 염은 Cu, Zn, Fe, Mg 또는 Mn 및 그의 염인 제조방법.The process of claim 6 wherein the bonding reaction is carried out in the presence of a catalyst, metal or metal salt, the catalyst is a mixture of a nickel compound, a palladium compound or a ligand and the metal or metal salt is Cu, Zn, Fe, Mg or Mn and Its salt. 제 8 항에 있어서, 카보닐 환원 반응은 팔라듐 탄소/수소, 레이니 니켈, 붕소 환원제, 알루미늄 환원제, 금속 철 분말, 아연 분말, Zn-Hg 및 히드라진 수화물을 포함하는 환원제이고, 가수분해 반응의 가수 분해제는 산 또는 염기인 제조방법.The method of claim 8, wherein the carbonyl reduction reaction is a reducing agent comprising palladium carbon / hydrogen, Raney nickel, boron reducing agent, aluminum reducing agent, metal iron powder, zinc powder, Zn-Hg and hydrazine hydrate, hydrolysis of the hydrolysis reaction The release is an acid or a base.
KR1020197035381A 2017-06-12 2018-05-23 Process for preparing substituted phenylacetic acid derivative KR20200008127A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710438332.1A CN109020808B (en) 2017-06-12 2017-06-12 Preparation method of substituted phenylacetic acid derivative
CN201710438332.1 2017-06-12
PCT/CN2018/087969 WO2018228149A1 (en) 2017-06-12 2018-05-23 Preparation method for substituted phenylacetic acid derivative

Publications (1)

Publication Number Publication Date
KR20200008127A true KR20200008127A (en) 2020-01-23

Family

ID=64628498

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197035381A KR20200008127A (en) 2017-06-12 2018-05-23 Process for preparing substituted phenylacetic acid derivative

Country Status (4)

Country Link
JP (1) JP2020520974A (en)
KR (1) KR20200008127A (en)
CN (1) CN109020808B (en)
WO (1) WO2018228149A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111423319B (en) * 2020-05-11 2022-11-04 上海应用技术大学 Preparation method of loxoprofen
CN111440059B (en) * 2020-05-14 2022-11-15 上海柏狮生物科技有限公司 Synthetic method of loxoprofen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2702911A1 (en) * 1977-01-21 1978-07-27 Schering Ag 4-Cycloalkyl- or 4-cyclo:alkanoyl-phenyl-acetic acid derivs. - used as systemic antiinflammatory agents
DD141422A5 (en) * 1978-01-27 1980-04-30 Schering Ag PROCESS FOR THE PREPARATION OF PHENYL ACID DERIVATIVES
CH645539A5 (en) * 1980-06-09 1984-10-15 Sankyo Co Anti-inflammatory agents for external application.
AR035016A1 (en) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd COMPOSITION OF AZOL PROMOTER OF PRODUCTION / SECRETION OF NEUROTROFINE, COMPOSITE PRODROGA OF THE SAME, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE OF THE SAME TO PREPARE THIS LAST.
MX2011011797A (en) * 2009-05-07 2011-11-29 Gruenenthal Gmbh Substituted phenyllureas and phenylamides as vanilloid receptor ligands.
CN103508869B (en) * 2013-10-24 2015-04-22 昆山力田医化科技有限公司 Synthetic method for 2-benzyl cyclopentanone
CN106316837B (en) * 2015-06-24 2020-04-24 浙江九洲药业股份有限公司 Preparation method of substituted phenylacetic acid derivative

Also Published As

Publication number Publication date
CN109020808A (en) 2018-12-18
WO2018228149A1 (en) 2018-12-20
JP2020520974A (en) 2020-07-16
CN109020808B (en) 2021-07-06

Similar Documents

Publication Publication Date Title
JPS582935B2 (en) 5↓-Production method of aroylpyrrole derivative
JP5091929B2 (en) Method for producing benzoic acids
JP2006312632A (en) Preparation method for telmisartan
KR20200008127A (en) Process for preparing substituted phenylacetic acid derivative
CN113735701A (en) Preparation method of 8-hydroxy-2,2,14, 14-tetramethylpentadecanedioic acid
CN107250102B (en) Method for producing benzidine from azobenzene by ruthenium catalysis
CN109553518B (en) Preparation method of substituted phenylacetic acid derivative
EP1868980B1 (en) New method for the preparation of 6-(3-(1-adamantyl)-4-methoxphenyl)-2-naphthoic acid
CN105884807A (en) Pinacol borate derivative preparation method and thioacetate compound preparation method
JP2000327603A (en) Production of propionic acid derivative
US4393008A (en) 2-Cyano-2-(3-phenoxy-phenyl)-propionic acid amide and preparation thereof
Kleinspehn et al. A Proof of Structure for 2-Bromo-3-methyl-4-carbethoxypyrrole1
JP2005504019A (en) Method for preparing isocoumarin
JP3544727B2 (en) Method for preparing 2,4,5-tribromopyrrole-3-carbonitrile
JPH0841029A (en) 3-substituted quinoline-5-carboxylic acid derivative and itsproduction
NO149387B (en) PROCEDURE FOR THE PREPARATION OF 6,11-DIHYDRO-11-OXODODIBENZE (B, E) -EXSEPINAL CANCER ACIDS
JP3869531B2 (en) Production method of biphenyl derivatives
JP2552436B2 (en) Method for producing benzo [a] quinolidinone derivative
JPS5821626B2 (en) The best way to get started
JP4096233B2 (en) Process for producing trifluoromethylphenylbenzoate derivative
JP3563424B2 (en) Method for producing 4H-pyran-4-one
US5675034A (en) Process for preparing 2-(p-fluorophenyl)-2 methyl-propionic acid and 3-(p-fluorophenyl)-2-methylpropionic acid derivatives
JPS602296B2 (en) Unsaturated carboxylic acid and its production method
WO2001029003A1 (en) Process for the preparation of 1-(6-methylpyridin-3-yl)-2-(4-methylthiophenyl)-ethanone and its use in the synthesis of diarylpyridines
JP2615780B2 (en) Method for producing 2-cyclopentenone derivative

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application